With COVID-19 vaccines now available worldwide, reaching underserved and vulnerable populations is a priority under…
With COVID-19 vaccines now available worldwide, reaching underserved and vulnerable populations is a priority under the Immunization Agenda 2030 (IA2030). Numerous challenges and operational issues have presented themselves in fragile contexts including vaccine access, risk of vaccine preventable diseases, and vaccine hesitancy. Join the IA2030 Strategic Priority 5 working group for a 90-minute webinar (May 21 at 13:30 CET) hosted by the International Vaccine Access Center to discuss vaccinating against COVID-19 in fragile contexts in coordination with the launch of IA2030 at the World Health Assembly.
Live translations available in Arabic, French, and Spanish during the webinar.
Moderated by William Moss, MD, MPH, Executive Director at the International Vaccine Access Center
Panelists include:
Kate O’Brien, MD, MPH, Director of Immunization, Vaccines & Biologicals Department (IVB) at the World Health Organization
Natasha Crowcroft, MD, MSc, MRCP, FFPH, Senior Technical Adviser, Measles and Rubella, and IVB at the World Health Organization
Aguide Soumouk, Immunization Team Lead, IFRC Country Office, Central African Republic
Yaser Najib, Senior Medical Officer at the Syria Immunization Group, Gaziantep, Turkey
Eba Al-muna Pasha, Global Health Cluster COVID-19 Task Team Focal Point
Ghulam Dastagir Nazary, MD, Director at Afghanistan National Expanded Program on Immunzation
With COVID-19 vaccines now available worldwide, reaching underserved and vulnerable populations is a priority under the Immunization Agenda 2030 (IA2030). Numerous challenges and operational issues have presented themselves in fragile contexts including vaccine access, risk of vaccine preventable d…
With COVID-19 vaccines now available worldwide, reaching underserved and vulnerable populations is a priority under the Immunization Agenda 2030 (IA2030). Numerous challenges and operational issues have presented themselves in fragile contexts including vaccine access, risk of vaccine preventable diseases, and vaccine hesitancy. Join the IA2030 Strategic Priority 5 working group for a 90-minute webinar (May 21 at 13:30 CET) hosted by the International Vaccine Access Center to discuss vaccinating against COVID-19 in fragile contexts in coordination with the launch of IA2030 at the World Health Assembly.
Live translations available in Arabic, French, and Spanish during the webinar.
Moderated by William Moss, MD, MPH, Executive Director at the International Vaccine Access Center
Panelists include:
Kate O’Brien, MD, MPH, Director of Immunization, Vaccines & Biologicals Department (IVB) at the World Health Organization
Natasha Crowcroft, MD, MSc, MRCP, FFPH, Senior Technical Adviser, Measles and Rubella, and IVB at the World Health Organization
Aguide Soumouk, Immunization Team Lead, IFRC Country Office, Central African Republic
Yaser Najib, Senior Medical Officer at the Syria Immunization Group, Gaziantep, Turkey
Eba Al-muna Pasha, Global Health Cluster COVID-19 Task Team Focal Point
Ghulam Dastagir Nazary, MD, Director at Afghanistan National Expanded Program on Immunzation
